10.1016/j.peptides.2019.170194 14
After your first semaglutide injection, peak plasma concentration occurs within 1 to 3 days
Appetite Suppression: A 2010 research study by Shrestha et al revealed that MT-II triggers the central melanocortin receptors and causes changes in hypothalamic neural networks that regulate appetite
Compared with oral administration or the extremely difficult intra-articular injection into small joints, MNs offered a minimally invasive, painless transdermal drug delivery system
A majority of the events occurred in patients who experienced nausea, vomiting, or diarrhea, leading to volume depletion
Limited Human Clinical Data The most significant limitation is the scarcity of rigorous, peer-reviewed human clinical trials: Few independent clinical trials published in peer-reviewed scientific journals Most efficacy data derived from manufacturer-sponsored studies or in silico modeling No large-scale, multi-center clinical trials examining long-term outcomes Limited data on optimal concentration, application frequency, and treatment duration Demographic diversity of studied populations not well-characterized The primary human efficacy data comes from a 50-subject study and various smaller manufacturer trials, representing a narrow evidence base for such a widely used cosmetic ingredient
